The Cost Effectiveness of Anticoagulation Management Services for Patients with Atrial Fibrillation and at High Risk of Stroke in the US

Author： Sullivan Patrick W.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.24, Iss.10, 2006-01, pp. : 1021-1033

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ximelagatran Cost Effectiveness for Stroke Prevention in Atrial Fibrillation

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 35, Iss. 4, 2005-12 ,pp. : 279-283

John Wiley & Sons Inc

Access to resources Recommend Favorite

Secondary Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation: Optimal Intensity of Anticoagulation

By Yasaka M.   Yamaguchi T.  

CNS Drugs, Vol. 15, Iss. 8, 2001-01 ,pp. : 623-631

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Therapies for Atrial Fibrillation: A Review

By Teng M.P.  

PharmacoEconomics, Vol. 18, Iss. 4, 2000-10 ,pp. : 317-333

Adis International

Access to resources Recommend Favorite

Anticoagulation prescription in atrial fibrillation

By Bertomeu-Gonzáález Vicente   Cordero Alberto   Mazóón Pilar   Moreno-Arribas Joséé   Fáácila Lorenzo   Nuññez Julio   Rodrííguez-Maññero Moiséés   Cosíín-Sales Juan   Gonzáález-Juanatey Jose Ramóón   Quiles Juan   Bertomeu-Martíínez Vicente  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 10, 2011-07 ,pp. : 1473-1479

Informa Healthcare

Access to resources Recommend Favorite

Anticoagulation for Stroke Prevention: High Effectiveness, More Cost Benefit?

By Shantsila Eduard   Watson Timothy   Lip Gregory Y.H.  

PharmacoEconomics, Vol. 24, Iss. 10, 2006-01 ,pp. : 1035-1038

Adis International

Access to resources Recommend Favorite